Skip to Main Content

Hello, everyone, and how are you today? We are just fine, thank you, despite gloomy skies hovering over the sleepy Pharmalot campus. Our spirits remain sunny thanks, in part, to sage advice from the Morning Mayor: “Every brand new day should be unwrapped like a precious gift.” So while you tug on the ribbon, we will indulge in a few more cups of stimulation and continue our quest for items of interest. Speaking of which, here are some tidbits. Hope your day is simply smashing and do drop us a line when interesting developments pop up in your vicinity …

Horizon Pharma (HZNP) has again raised the average wholesale price of Vimovo, a common painkiller combined with a drug that prevents stomach irritation, by 9.9 percent, and a bottle of 60 pills now costs $2,979, The Financial Times writes. Horizon acquired U.S. rights to the medicine in November 2013 from AstraZeneca (AZN), which charged $138 per bottle. Since then, Horizon has raised the price on 11 occasions, including earlier this month, by an aggregate of more than 2,000 percent. If purchased individually, the drugs can cost as little as $36 and both are available in over-the-counter forms.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • A question for our scribe – am I imagining that this sounds like a story once featured in an ancestral version of Pharmalot?

    “A former senior analytical chemist at Merck (MRK) was arrested for stealing and then improperly disposing of 219 grams of potassium cyanide taken from company labs.”

Comments are closed.